These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 9156364)
81. Activation of IP prostanoid receptors prevents cardiomyocyte hypertrophy via cAMP-dependent signaling. Ritchie RH; Rosenkranz AC; Huynh LP; Stephenson T; Kaye DM; Dusting GJ Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1179-85. PubMed ID: 15072955 [TBL] [Abstract][Full Text] [Related]
82. Competitive antagonism at thromboxane receptors in human platelets. Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580 [TBL] [Abstract][Full Text] [Related]
83. Pulmonary versus systemic effects of vasodilator drugs: an in vitro study in isolated intrapulmonary and mesenteric arteries of neonatal piglets. Pérez-Vizcaíno F; Villamor E; Moro M; Tamargo J Eur J Pharmacol; 1996 Oct; 314(1-2):91-8. PubMed ID: 8957223 [TBL] [Abstract][Full Text] [Related]
84. Characterization of a prostanoid EP3-receptor in guinea-pig aorta: partial agonist action of the non-prostanoid ONO-AP-324. Jones RL; Qian YM; Chan KM; Yim AP Br J Pharmacol; 1998 Nov; 125(6):1288-96. PubMed ID: 9863659 [TBL] [Abstract][Full Text] [Related]
85. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery. Lydford SJ; McKechnie KC; Dougall IG Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337 [TBL] [Abstract][Full Text] [Related]
86. Prostacyclin analogs stimulate receptor-mediated cAMP synthesis and ATP release from rabbit and human erythrocytes. Sprague RS; Bowles EA; Hanson MS; DuFaux EA; Sridharan M; Adderley S; Ellsworth ML; Stephenson AH Microcirculation; 2008 Jul; 15(5):461-71. PubMed ID: 18574748 [TBL] [Abstract][Full Text] [Related]
87. Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension. Asaki T; Kuwano K; Morrison K; Gatfield J; Hamamoto T; Clozel M J Med Chem; 2015 Sep; 58(18):7128-37. PubMed ID: 26291199 [TBL] [Abstract][Full Text] [Related]
88. Interactions of iloprost and sodium nitroprusside on vascular smooth muscle and platelet aggregation. Lidbury PS; Antunes E; de Nucci G; Vane JR Br J Pharmacol; 1989 Dec; 98(4):1275-80. PubMed ID: 2482103 [TBL] [Abstract][Full Text] [Related]
89. Prostacyclin receptor desensitization is a reversible phenomenon in human platelets. Fisch A; Tobusch K; Veit K; Meyer J; Darius H Circulation; 1997 Aug; 96(3):756-60. PubMed ID: 9264479 [TBL] [Abstract][Full Text] [Related]
90. Differential effects of prostacyclin and iloprost in the isolated carotid artery of the guinea-pig. Corriu C; Félétou M; Edwards G; Weston AH; Vanhoutte PM Eur J Pharmacol; 2001 Aug; 426(1-2):89-94. PubMed ID: 11525776 [TBL] [Abstract][Full Text] [Related]
91. Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism. Crutchley DJ; Solomon DE; Conanan LB Arterioscler Thromb; 1992 Jun; 12(6):664-70. PubMed ID: 1375507 [TBL] [Abstract][Full Text] [Related]
92. Use of prostacyclin and its analogues in the treatment of cardiovascular disease. Fink AN; Frishman WH; Azizad M; Agarwal Y Heart Dis; 1999; 1(1):29-40. PubMed ID: 11720602 [TBL] [Abstract][Full Text] [Related]
93. Pharmacophore definition and three-dimensional quantitative structure-activity relationship study on structurally diverse prostacyclin receptor agonists. Stoll F; Liesener S; Hohlfeld T; Schrör K; Fuchs PL; Höltje HD Mol Pharmacol; 2002 Nov; 62(5):1103-11. PubMed ID: 12391273 [TBL] [Abstract][Full Text] [Related]
94. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein. Lawrence RA; Jones RL Br J Pharmacol; 1992 Apr; 105(4):817-24. PubMed ID: 1324050 [TBL] [Abstract][Full Text] [Related]
95. Prostacyclin effects on adenylate cyclase in platelets and vascular smooth muscle: interaction with an inhibitory receptor or partial agonism? Rovati GE; Giovanazzi S; Negretti A; Nicosia S Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():263-5. PubMed ID: 7732849 [No Abstract] [Full Text] [Related]
96. A novel subtype of the prostacyclin receptor expressed in the central nervous system. Takechi H; Matsumura K; Watanabe Y; Kato K; Noyori R; Suzuki M; Watanabe Y J Biol Chem; 1996 Mar; 271(10):5901-6. PubMed ID: 8621463 [TBL] [Abstract][Full Text] [Related]
97. Activation of IP and EP(3) receptors alters cAMP-dependent cell migration. Blindt R; Bosserhoff AK; vom Dahl J; Hanrath P; Schrör K; Hohlfeld T; Meyer-Kirchrath J Eur J Pharmacol; 2002 May; 444(1-2):31-7. PubMed ID: 12191579 [TBL] [Abstract][Full Text] [Related]